Table 6 The characteristics of cardiac magnetic resonance of the patients before and after treatment
No. | Immunosuppressive treatment | Interval between two CMR test(months) | Before treatment | After treatment | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
LV EF (%) | RV EF (%) | Hypoperfusion/location | Gadolinium/location | LV EF (%) | RV EF (%) | Hypoperfusion/location | Gadolinium/location | |||
1 | CTX + G | 5.7 | 51.2 | 42.9 | LV inferior | LV + RV diffuse subendocardial | 38.6 | 19.9 | Ventricle septal + LV | LV + RV diffuse subendocardial |
2 | MMF + G | 16.2 | 51.8 | 35.5 | LV apical | 44.4 | 30.5 | LV apical | ||
3 | CTX + G | 6.3 | 31.5 | 22.8 | LV + RV subendocardial | 26.4 | 22.5 | LV + RV subendocardial | ||
4 | CTX + G | 5.9 | 77.7 | 68.2 | Ventricular septal + LV | 67.6 | 62.4 | Ventricular septal + LV | ||
5 | N | 32.9 | 57 | 60.6 | Ventricular septal | 56.3 | 47.7 | Ventricular septal | ||
6 | CTX + G | 26.4 | 42.4 | 50.6 | LV lateral | Ventricular septal + LV | 43.7 | 48.4 | LV lateral | Ventricular septal + LV |